It has previously been reported that siRNA-mediated reduction of HSP90 sensitized glioblastoma cells to TRAIL apoptosis by effects on cFLIP, suggesting that cFLIP is an HSP90 client protein and that reduced levels of HSP90 prevented appropriate trafficking of cFLIP to the TRAIL DISC.38 Thus, the effects of withanolide E are consistent with HSP90 inhibition leading to misfolding and/or aggregation of cFLIP culminating in cFLIP degradation. Here, CFLAR is linked to glioblastoma.